{
    "2020-11-04": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Republican Hold On Senate Seen As Plus For Drug Companies",
                "features": {
                    "keywords": [
                        "Republican",
                        "Hold",
                        "Senate",
                        "Drug",
                        "Companies"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Novavax Announces Covid-19 Vaccine Supply Deal With Australia",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Covid-19",
                        "Vaccine",
                        "Supply",
                        "Australia"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Psychedelic Drug Stock Jumps After State Ballot Legalizes Therapy",
                "features": {
                    "keywords": [
                        "Psychedelic",
                        "Drug",
                        "Stock",
                        "State",
                        "Ballot",
                        "Legalizes",
                        "Therapy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Chilean president says regulators okay AstraZeneca COVID vaccine trial",
                "features": {
                    "keywords": [
                        "Chilean",
                        "president",
                        "regulators",
                        "AstraZeneca",
                        "COVID",
                        "vaccine",
                        "trial"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Zacks Analyst Blog Highlights: Google, Johnson & Johnson, Union Pacific Corp, Eli Lilly, Charter Communications and Anheuser-Busch InBev",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Google",
                        "Johnson & Johnson",
                        "Union Pacific Corp",
                        "Eli Lilly",
                        "Charter Communications",
                        "Anheuser-Busch InBev"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "transportation",
                        "communications",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}